Fact sheet: Carnegie Medical

Fund information

Fund name
Carnegie Medical 1A EUR
Fund company manager
Carnegie Asset Management
Fund type
SIB
Fund manager(s)
Angelica Fatouros
since 01/07/2008
Fund objective
The investment objective of the C WorldWide Medical fund is to achieve long-term capital growth by investing globally in a limited number of companies within the healthcare sector. Most of the investments are in the major pharmaceutical companies, but also in smaller and medium-sized companies.
Benchmark
MSCI World Healthcare
Investment style
Growth
Investment method
Shares

Performance snapshot

Sector
Fund
Sector
Fund
Sector
Fund

Quick stats

1 Year return

3.39 %

1 Year rank in sector

26/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 474.4 m

FE Risk score

162

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • North America
    76.8%
  • Continental Europe
    20.4%
  • UK
    2.8%
  • Pharmaceuticals
    42.8%
  • Biotechnology/Medical
    38.5%
  • Services
    18.7%
  • North American Equities
    76.8%
  • European Equities
    20.4%
  • UK Equities
    2.8%

Performance vs. Sector

Sector
Fund
Sector
Fund
Sector
Fund

Cumulative performance

1m6m1y3y5y
Fund3.15 %-1.12 %3.39 %-0.66 %75.45 %
Sector1.73 %2.49 %14.74 %11.81 %96.93 %
Rank within sector12 / 3024 / 3026 / 2921 / 2618 / 22
Quartile th2 nd4 th4 th4 th4 th

Calendar performance

YTD-20172016201520142013
Fund3.19 %-14.37 %10.68 %38.82 %31.94 %
Sector14.51 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector26 / 2920 / 2910 / 264 / 2316 / 22
Quartile th4 th3 rd2 nd1 st3 rd

Risk statistics

Alpha-4.16
Beta1.11
Sharpe-0.01
Volatility18.28
Tracking error7.1
Information ratio-0.58
R-Squared0.86

Price movement

52 week high101.85
52 week low89.19
Current bid price0
Current offer price0
Current mid price93.27

Holdings by region

  • 76.8% North America
  • 20.4% Continental Europe
  • 2.8% UK

Holdings by sector

  • 42.8% Pharmaceuticals
  • 38.5% Biotechnology/Medical
  • 18.7% Services

Holdings by asset type

  • 76.8% North American Equities
  • 20.4% European Equities
  • 2.8% UK Equities

Individual holdings

  • 7.7% JOHNSON & JOHNSON
  • 7% UNITEDHEALTH GROUP INC
  • 5.3% GILEAD SCIENCES INC
  • 5.1% C WORLDWIDE MEDICAL SMALL & MID CAP
  • 3.6% AMGEN INC
  • 3.6% ROCHE HLDG AG
  • 3.3% PFIZER INC
  • 3.2% ACTAVIS INC
  • 3.2% THERMO FISHER SCIENTIFIC INC
  • 3.1% CELGENE CORP